Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.
Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target
Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.
